Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in ...
Bristol-Myers Squibb Company (BMY) stock price is 58.95 and Bristol-Myers Squibb Company (BMY) 10-day simple moving average is 58.57. Bristol-Myers Squibb Company (BMY) stock price is ...
More than 40 groups have signed onto a letter asking Congress to end the prescription drug price control scheme included in the Inflation Reduction Act. President Biden is set to lay out his ...
Wells Fargo raised the firm’s price target on Bristol Myers (BMY) to $62 from $60 and keeps an Equal Weight rating on the shares. While ...
Analysts at Cantor Fitzgerald increased their FY2024 earnings estimates for shares of Bristol-Myers Squibb in a research note issued to investors on Tuesday, February 4th. Cantor Fitzgerald analyst O.
Bristol Myers Squibb & Co (NYSE:BMY) posted fourth-quarter revenues of $12.34 billion, beating the consensus of $11.57 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback